Silence Therapeutics Final results for the year ended 31 December 2019
April 14, 2020 07:00 ET
|
Silence Therapeutics
Final results for the year ended 31 December 2019 April 14, 2020 LONDON, Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of...
SLN124 granted Orphan Drug Designation by EMA for the treatment of β-Thalassemia
January 15, 2019 07:00 ET
|
Silence Therapeutics
SLN124 granted Orphan Drug Designation by EMA for the treatment of β-Thalassemia January 15, 2019 LONDON, Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery,...